Health Catalyst, a data, analytics and decision support company, closed a series F equity and debt funding round with access to up to $100 million in capital. This brings up the company's value to more than $1 billion.
The company will use the new funds to expand Health Catalyst's technology and services offerings, including the Health Catalyst Data Operating System, a data warehouse and application development platform. It will also support the company's "expansion, already underway, into the life sciences and international markets," said Health Catalyst CEO Dan Burton.
OrbiMed, a healthcare public and private market investment firm, led the equity and debt funding round. Other investors were Sequoia Capital, UPMC Enterprises and Kaiser Permanente Ventures.